4.2 Article

Validity and Reliability Assessment of a Japanese Version of the Snaith-Hamilton Pleasure Scale

Journal

INTERNAL MEDICINE
Volume 51, Issue 8, Pages 865-869

Publisher

JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.51.6718

Keywords

Parkinson's disease; anhedonia; Snaith-Hamilton pleasure scale; validity; reliability

Ask authors/readers for more resources

Objective Anhedonia is one of the main non-motor symptoms in Parkinson's disease (PD); it is assessed using the Snaith-Hamilton pleasure scale (SHAPS). To assess anhedonia in the Japanese population, we prepared a Japanese language version of SHAPS (SHAPS-J), and evaluated its validity and reliability in 8 neurological centers. Seventy subjects (48 patients with PD and 22 healthy subjects) were enrolled in this study. Methods The validity of the test was assessed by the correlation between SHAPS-J and the apathy scale, based on the fact that anhedonia is considered a symptom of apathy syndrome. Test-retest reliability and internal consistency were assessed by Cohen's kappa and Cronbach's alpha coefficients, respectively. Results In the evaluation of validity, the total scores obtained on SHAPS-J during the test and retest significantly correlated with scores on Item 4 in Part 1 of the unified Parkinson's disease rating scale (p<0.0008 and p<0.0036, respectively). Cohen's kappa coefficient was >0.3 on all items (p<0.0005 on all items). Cronbach's alpha coefficient was 0.90 at the baseline and 0.88 at the retest. Conclusion These results indicate that SHAPS-J has good validity, test-retest reliability, and internal consistency, thus establishing an available measure of anhedonia in Japanese.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Fiber-specific white matter analysis reflects upper motor neuron impairment in amyotrophic lateral sclerosis

Aya Ogura, Kazuya Kawabata, Hirohisa Watanabe, Shao Wei Choy, Epifanio Bagarinao, Toshiyasu Kato, Kazunori Imai, Michihito Masuda, Reiko Ohdake, Kazuhiro Hara, Ryoichi Nakamura, Naoki Atsuta, Tomohiko Nakamura, Masahisa Katsuno, Gen Sobue

Summary: In this study, a novel framework for diffusion-weighted imaging analysis called Fixel-based analysis (FBA) was used to investigate white matter changes in ALS patients. The findings showed reduced fiber density and morphology in the bilateral corticospinal tracts and corpus callosum of ALS patients. Clinical scores were negatively correlated with fiber density values in the corticospinal tracts.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Geriatrics & Gerontology

Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis

Genki Tohnai, Ryoichi Nakamura, Naoki Atsuta, Masahiro Nakatochi, Naoki Hayashi, Daisuke Ito, Hazuki Watanabe, Hirohisa Watanabe, Masahisa Katsuno, Yuishin Izumi, Akira Taniguchi, Kazuaki Kanai, Mitsuya Morita, Osamu Kano, Satoshi Kuwabara, Masaya Oda, Koji Abe, Masashi Aoki, Ikuko Aiba, Koichi Okamoto, Kouichi Mizoguchi, Tomohiko Ishihara, Akihiro Kawata, Takanori Yokota, Kazuko Hasegawa, Isao Nagano, Ichiro Yabe, Fumiaki Tanaka, Satoshi Kuru, Nobutaka Hattori, Kenji Nakashima, Ryuji Kaji, Gen Sobue

Summary: This study aimed to determine the frequencies and characteristics of DNAJC7 gene variants in a Japanese ALS cohort. Rare missense variants and one splice-site variant of DNAJC7 were detected in 807 Japanese patients with sporadic ALS. The variants were located around the TPR domain and the estimated frequency of DNAJC7 variants in Japanese ALS patients was 0.87%.

NEUROBIOLOGY OF AGING (2022)

Article Clinical Neurology

Altered gut microbiota in Parkinson's disease patients with motor complications

Kai Takahashi, Hiroshi Nishiwaki, Mikako Ito, Kazuhiro Iwaoka, Kenta Takahashi, Yoshio Suzuki, Keita Taguchi, Kanako Yamahara, Yoshio Tsuboi, Kenichi Kashihara, Masaaki Hirayama, Kinji Ohno, Tetsuya Maeda

Summary: The study revealed that the relative abundance of gut microbiota is associated with motor complications in Parkinson's disease patients, with differences in effects between wearing-off and dyskinesia. Age, disease duration, and wearing-off were identified as independent risk factors for microbiota changes.

PARKINSONISM & RELATED DISORDERS (2022)

Article Neurosciences

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

M. Judith Peterschmitt, Hidemoto Saiki, Taku Hatano, Thomas Gasser, Stuart H. Isaacson, Sebastiaan J. M. Gaemers, Pascal Minini, Stephane Saubadu, Jyoti Sharma, Samantha Walbillic, Roy N. Alcalay, Gary Cutter, Nobutaka Hattori, Gunter U. Hoeglinger, Kenneth Marek, Anthony H. Schapira, Clemens R. Scherzer, Tanya Simuni, Nir Giladi, Sergio Pablo Sardi, Tanya Z. Fischer

Summary: This study evaluated the pharmacology, safety, and tolerability of the glucosylceramide synthase inhibitor venglustat in patients with Parkinson's disease and GBA mutations. The results showed favorable safety and tolerability of venglustat in both Japanese and non-Japanese participants, with target engagement achieved in cerebrospinal fluid.

JOURNAL OF PARKINSONS DISEASE (2022)

Article Clinical Neurology

White matter microstructures in Parkinson's disease with and without impulse control behaviors

Haruka Takeshige-Amano, Taku Hatano, Koji Kamagata, Christina Andica, Wataru Uchida, Masahiro Abe, Takashi Ogawa, Yasushi Shimo, Genko Oyama, Atsushi Umemura, Masanobu Ito, Masaaki Hori, Shigeki Aoki, Nobutaka Hattori

Summary: This study comprehensively assessed white matter microstructures in PD patients with ICBs using advanced diffusion MRI and MT-sat imaging. The results showed that compared with healthy controls, PD-nICBs had significant alterations in many major white matter tracts in most parameters. Compared with PD-ICBs, PD-nICBs had more prominent myelin and axonal changes in fibers related to the reward system and visual emotional recognition.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

Article Clinical Neurology

Current Status of Telemedicine for Parkinson's Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey

Mayuko Ogawa, Genko Oyama, Satoko Sekimoto, Taku Hatano, Nobutaka Hattori

Summary: In a specific cohort in Japan, patients with Parkinson's disease and their caregivers were mostly satisfied with the telemedicine service, finding it effective in reducing travel burden.

JOURNAL OF MOVEMENT DISORDERS (2022)

Review Clinical Neurology

Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders

Conor Fearon, Sapna Rawal, Diana Olszewska, Paula Alcaide-Leon, Drew S. Kern, Soumya Sharma, Shyam K. Jaiswal, Jagarlapudi M. K. Murthy, Ainhi D. Ha, Raymond S. Schwartz, Victor S. C. Fung, Chauncey Spears, Tracy Tholanikunnel, Leonardo Almeida, Taku Hatano, Yutaka Oji, Nobutaka Hattori, Shantanu Shubham, Hrishikesh Kumar, Roongroj Bhidayasiri, Christopher Laohathai, Anthony E. Lang

Summary: The MDS Video Challenge is one of the most attended sessions at the International Congress. In addition to presenting complex case videos, over the years, there have been cases with unusual or important neuroimaging findings. This review compiles a selection of such cases and presents them in two anthologies based on whether the underlying diagnosis is genetic or acquired.

MOVEMENT DISORDERS CLINICAL PRACTICE (2022)

Review Clinical Neurology

Multiple System Atrophy: Advances in Diagnosis and Therapy

Hirohisa Watanabe, Sayuri Shima, Yasuaki Mizutani, Akihiro Ueda, Mizuki Ito

Summary: This review summarizes the improvements in understanding the pathophysiology and early clinical symptoms of multiple system atrophy (MSA), as well as advancements in diagnostic methods and disease-modifying therapies for the condition. The introduction of new diagnostic criteria in 2022 and the use of artificial intelligence and machine learning in neuroimaging have significantly improved diagnostic accuracy. Treatment advancements, including immunotherapy against alpha-synuclein and stem cell therapies, show promise in targeting different aspects of the disease.

JOURNAL OF MOVEMENT DISORDERS (2023)

Review Biochemistry & Molecular Biology

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification

Naoto Sugeno, Takafumi Hasegawa

Summary: Alpha-synuclein (aS) is a protein encoded by the SNCA gene that is involved in Parkinson's disease (PD). Mutations and multiplication of the SNCA gene lead to familial forms of PD. Misfolded aS is cytotoxic and forms Lewy bodies, a hallmark of PD. The expression of SNCA and epigenetic alterations play a role in the pathogenesis of sporadic PD. RNA sequencing and informatic analysis of human midbrain-like organoids can provide insights into novel pathways for the development of PD therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Clinical Neurology

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease

Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, Shosuke Ito, Kazumasa Wakamatsu, Fabio A. Zucca, Luigi Zecca, Moussa Youdim, Maximilian Wulf, Peter Riederer, Johannes M. Dijkstra

Summary: The dark pigment neuromelanin (NM) is abundant in dopamine (DA) neurons in the substantia nigra (SN) and norepinephrine (NE) neurons in the locus coeruleus (LC) in the human brain. During the progression of Parkinson's disease (PD), NM levels in these neurons decrease. The synthesis pathway involves conversion of tyrosine to L-DOPA, then to DA or NE, followed by autoxidation and conversion to eumelanic or pheomelanic NM.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Clinical Neurology

Olfactory Dysfunction, an Often Neglected Symptom of Hydrocephalus: Experience from a Case of Late-Onset Idiopathic Aqueductal Stenosis

Naoya Yamazaki, Takafumi Hasegawa, Kensuke Ikeda, Ako Miyata, Shin-ichiro Osawa, Kuniyasu Niizuma, Shigenori Kanno, Teiji Tominaga, Masashi Aoki

Summary: Disturbance of smell is often associated with neurodegenerative diseases and can also be caused by head trauma, intracranial tumors, and hydrocephalus. Olfactory dysfunction is often overlooked due to the prominence of motor symptoms. This case report highlights that hydrocephalus can cause olfactory dysfunction and that it can be improved with surgical treatment.

CASE REPORTS IN NEUROLOGY (2023)

Article Clinical Neurology

A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease

Yoko Sugimura, Toru Baba, Michinori Ezura, Akio Kikuchi, Takafumi Hasegawa, Isao Nagano, Kyoko Suzuki, Atsushi Takeda

Summary: Corticobasal syndrome is characterized by asymmetric akinetic rigidity and higher cortical dysfunction. Predicting its pathology is challenging, but clinical and neuroimaging findings can provide clues. Visuospatial dysfunction and language impairment indicate Alzheimer's disease-related pathology, aiding in distinguishing it from other types. Early diagnosis based on clinical features and biomarkers is crucial for successful intervention in corticobasal syndrome associated with Alzheimer's disease.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2023)

Review Medicine, General & Internal

Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review

Takafumi Kubota, Tomomi Shijo, Kensho Ikeda, Yoshihiko Mitobe, Shu Umezawa, Tatsuro Misu, Takafumi Hasegawa, Masashi Aoki

Summary: We report a rare case of distal chronic inflammatory demyelinating polyneuropathy (CIDP) following COVID-19 vaccination. A 39-year-old woman developed general weakness after receiving the Pfizer-BioNTech COVID-19 vaccine, which progressed over 3 months. The patient was diagnosed with distal CIDP based on neurological examination and serological tests. Treatment with immunoglobulin, methylprednisolone, prednisolone, and plasma exchange resulted in gradual improvement. Physicians should be aware of CIDP as a rare complication of COVID-19 vaccination.

INTERNAL MEDICINE (2023)

Article Medicine, General & Internal

Dramatic Responses to Low-Dose Pramipexole in Painful Legs and Moving Toes Syndrome

Gakusuke Umezawa, Takafumi Hasegawa, Kensuke Ikeda, Genichi Saito, Masashi Aoki

Summary: Painful legs and moving toes syndrome (PLMTS) is a rare movement disorder characterized by spontaneous abnormal toe movements and leg pain. It mainly affects middle-aged or older women. The cause of PLMTS is often unknown, but it can be related to peripheral neuropathy, trauma history, or nerve root damage. Treatment for PLMTS includes medication such as anticonvulsants and antidepressants, as well as therapeutic interventions like botulinum toxin injection and epidural block. We report a case where low doses of pramipexole, a non-ergot dopamine agonist, significantly improved both abnormal toe movement and leg pain.

CUREUS JOURNAL OF MEDICAL SCIENCE (2023)

Article Medicine, General & Internal

Rare presentation of tuberculous hypertrophic pachymeningitis diagnosed by a biopsy of abdominal lymphadenopathy

Makiko Yoshida, Naoki Ishizuka, Masanori Mizuno, Manami Maeta, Tetsuya Maeda

Summary: We report a rare case of tuberculous hypertrophic pachymeningitis in a patient with abdominal tuberculous lymphadenopathy. Systematic investigation of tuberculosis is crucial for the diagnosis of pachymeningitis.

SAGE OPEN MEDICAL CASE REPORTS (2022)

No Data Available